Laddar...
Design Considerations for Dose-Expansion Cohorts in Phase I Trials
Phase I trials are increasingly including dose-expansion cohorts after the maximum-tolerated dose (MTD) has been reached to better characterize the toxicity profile or identify early signs of efficacy within a specific disease population. This article provides guidelines on how to monitor safety and...
Sparad:
| I publikationen: | J Clin Oncol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society of Clinical Oncology
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979131/ https://ncbi.nlm.nih.gov/pubmed/24101039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.47.9949 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|